Cardiovascular Disease in Type 2 Diabetes Mellitus
Open Access
- 13 January 2003
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 163 (1) , 33-40
- https://doi.org/10.1001/archinte.163.1.33
Abstract
Review from JAMA Internal Medicine — Cardiovascular Disease in Type 2 Diabetes Mellitus — Current Management GuidelinesKeywords
This publication has 23 references indexed in Scilit:
- Faculty Opinions recommendation of Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study.Published by H1 Connect ,2017
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation, 2002
- Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)BMJ, 2001
- A Rational Approach to Drug Therapy of Type 2 Diabetes MellitusDrugs, 2000
- Glucotoxicity: Potential MechanismsClinics in Geriatric Medicine, 1999
- Drug Therapy of Postprandial HyperglycaemiaDrugs, 1999
- Antioxidant nutrient intake and diabetic retinopathyOphthalmology, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in WomenAnnals of Internal Medicine, 1995
- Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic PatientsAnnals of Internal Medicine, 1993